References
- Abdelwahed W, Degobert G, Stainmesse S, Fessi H. (2006). Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev, 58:1688–1713.
- Westesen K, Bunjes H, Koch MHJ. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Control Release 48:223–236.
- Bunjes H, Westesen K, Koch MHJ. (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm 129:159–173.
- Jenning V, Gohla S. (2000). Comparison of wax and glyceride solid lipid nanoparticles (SLN). Int J Pharm, 196:219–222.
- Müller RH, Mäder K, Gohla S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art. Eur J Pharm Biopharm, 50:161–177.
- Westesen K, Siekmann B. (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm 151:35–45.
- Awad TS, Helgason T, Weiss J, Decker EA, McClements DJ. (2009). Effect of omega-3 fatty acids on crystallization, polymorphic transformation and stability of tripalmitin solid lipid nanoparticle suspensions. Cryst Growth Des 9:3405–3411.
- Carlotti ME, Sapino S, Peira E, Gallarate M, Ugazio E. (2009). On the photodegradation of dithranol in different topical formulations: use of sln to increase the stability of the drug. J Dispers Sci Technol 30:1517–1524.
- Kristl J, Volk B, Gasperlin M, Sentjurc M, Jurkovic P. (2003). Effect of colloidal carriers on ascorbyl palmitate stability. Eur J Pharm Sci, 19:181–189.
- Lee MK, Kim MY, Kim S, Lee J. (2009). Cryoprotectants for freeze drying of drug nano-suspensions: effect of freezing rate. J Pharm Sci, 98:4808–4817.
- Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Jafarian Dehkordi A, Kobarfard F. (2010). Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design. Pharm Dev Technol Nov 5th:1–8.
- Lu X, Howard MD, Mazik M, Eldridge J, Rinehart JJ, Jay M et al. (2008). Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization. AAPS J, 10:133–140.
- Lu X, Howard MD, Talbert DR, Rinehart JJ, Potter PM, Jay M et al. (2009). Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release. AAPS J, 11:120–122.
- Mumper RJ, Cui Z, Oyewumi MO. (2003). Nanotemplate engineering of cell specific nanoparticles. J Dispers Sci Technol 24:569–588.
- Greenspan L. (1977). Humidity fixed points of binary saturated aqueous solutions. J Res Natl Bur Stand 81:89–96.
- Kamiya S, Nozawa Y, Miyagishima A, Kurita T, Sadzuka Y, Sonobe T. (2006). Physical characteristics of freeze-dried griseofulvin-lipids nanoparticles. Chem Pharm Bull, 54:181–184.
- Ohshima H, Miyagishima A, Kurita T, Makino Y, Iwao Y, Sonobe T et al. (2009). Freeze-dried nifedipine-lipid nanoparticles with long-term nano-dispersion stability after reconstitution. Int J Pharm, 377:180–184.
- Choi KY, Min KH, Yoon HY, Kim K, Park JH, Kwon IC et al. (2011). PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials, 32:1880–1889.
- Heiati H, Tawashi R, Phillips NC. (1998). Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J Microencapsul, 15:173–184.
- Subramanian S, Dandekar P, Jain R, Pandey U, Samuel G, Hassan PA et al. (2010). Technetium-99m-labeled poly(DL-lactide-co-glycolide) nanoparticles as an alternative for sentinel lymph node imaging. Cancer Biother Radiopharm, 25:637–644.
- Cui Z, Hsu CH, Mumper RJ. (2003). Physical characterization and macrophage cell uptake of mannan-coated nanoparticles. Drug Dev Ind Pharm, 29:689–700.
- Sameti M, Bohr G, Ravi Kumar MN, Kneuer C, Bakowsky U, Nacken M et al. (2003). Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm, 266:51–60.
- Schwarz C, Mehnert W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm, 157:171–179.
- Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP et al. (1998). Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA, 95:4607–4612.
- Bochkova OD, et al. (2011). Silica nanoparticles with a substrate switchable luminescence. J Phys: Conf Ser 291:012038.
- Yen FL, Wu TH, Tzeng CW, Lin LT, Lin CC. (2010). Curcumin nanoparticles improve the physicochemical properties of curcumin and effectively enhance its antioxidant and antihepatoma activities. J Agric Food Chem, 58:7376–7382.
- De Jaeghere F, Allémann E, Feijen J, Kissel T, Doelker E, Gurny R. (2000). Freeze-drying and lyopreservation of diblock and triblock poly(lactic acid)-poly(ethylene oxide) (PLA-PEO) copolymer nanoparticles. Pharm Dev Technol, 5:473–483.
- Lee J, Cheng Y. (2006). Critical freezing rate in freeze drying nanocrystal dispersions. J Control Release, 111:185–192.
- Gura KM. (2009). Is there still a role for peripheral parenteral nutrition? Nutr Clin Pract, 24:709–717.
- Lim SJ, Kim CK. (2002). Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid. Int J Pharm, 243:135–146.
- Williams NA, Polli GP. (1984). The lyophilization of pharmaceuticals: a literature review. J Parenter Sci Technol, 38:48–59.
- de Chasteigner S, Cavé G, Fessi H, Devissaguet JP, Puisieux F. (1996). Freeze-drying of itraconazole-loaded nanosphere suspensions: a feasibility study. Drug Dev Res 38:116–124.
- Nango M, Yamamoto H, Joukou K, Ueda M, Katayama A, Kuroki N. (1980). Solubility of aromatic hydrocarbons in water and aqueous solutions of sugars. J Chem Soc Chem Commun 3:104–105.